- Home
- SGMT vs SPPP Comparison
SGMT vs SPPP Comparison
Compare SGMT & SPPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- SPPP
- Stock Information
- Founded
- SGMT 2006
- SPPP 2011
- Country
- SGMT United States
- SPPP Canada
- Employees
- SGMT N/A
- SPPP N/A
- Industry
- SGMT
- SPPP
- Sector
- SGMT
- SPPP
- Exchange
- SGMT Nasdaq
- SPPP NYSE
- Market Cap
- SGMT 128.5M
- SPPP 140.9M
- IPO Year
- SGMT 2023
- SPPP N/A
- Fundamental
- Price
- SGMT $3.72
- SPPP $9.76
- Analyst Decision
- SGMT Strong Buy
- SPPP
- Analyst Count
- SGMT 6
- SPPP 0
- Target Price
- SGMT $25.67
- SPPP N/A
- AVG Volume (30 Days)
- SGMT 315.0K
- SPPP 183.3K
- Earning Date
- SGMT 03-12-2025
- SPPP 01-01-0001
- Dividend Yield
- SGMT N/A
- SPPP N/A
- EPS Growth
- SGMT N/A
- SPPP N/A
- EPS
- SGMT N/A
- SPPP N/A
- Revenue
- SGMT N/A
- SPPP N/A
- Revenue This Year
- SGMT N/A
- SPPP N/A
- Revenue Next Year
- SGMT N/A
- SPPP N/A
- P/E Ratio
- SGMT N/A
- SPPP N/A
- Revenue Growth
- SGMT N/A
- SPPP N/A
- 52 Week Low
- SGMT $2.39
- SPPP $8.55
- 52 Week High
- SGMT $7.38
- SPPP $11.39
- Technical
- Relative Strength Index (RSI)
- SGMT 44.81
- SPPP 55.55
- Support Level
- SGMT $3.70
- SPPP $9.57
- Resistance Level
- SGMT $4.24
- SPPP $9.73
- Average True Range (ATR)
- SGMT 0.23
- SPPP 0.12
- MACD
- SGMT 0.04
- SPPP 0.00
- Stochastic Oscillator
- SGMT 45.70
- SPPP 66.67
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.